Literature DB >> 20012255

[Diagnostic pitfalls with Cushing's syndrome].

W Hunger-Battefeld1, M Gajda, A Hansch, A Mandecka, U A Müller, G Wolf.   

Abstract

Adrenal cortical carcinoma is a rare diagnosis and may present with hormone secretion. A histological differentiation between an adrenal cortical adenoma and carcinoma can be very difficult. However, a fast diagnosis including staging and complete surgical resection is pivotal for the prognosis of an adrenal cortical carcinoma. Metastasing adrenal cortical carcinoma should be treated with a mitotane based chemotherapy, and inclusion in the "firm-act study" is highly recommended. The present case report demonstrates the diagnostic pitfalls in a female patients with Cushing's syndrome who suffered from metastasing adrenal cortical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20012255     DOI: 10.1007/s00108-009-2493-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

1.  Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma.

Authors:  R D Schulick; M F Brennan
Journal:  Ann Surg Oncol       Date:  1999-12       Impact factor: 5.344

2.  Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.

Authors:  P Icard; P Goudet; C Charpenay; B Andreassian; B Carnaille; Y Chapuis; P Cougard; J F Henry; C Proye
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

3.  Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors.

Authors:  Sébastien Aubert; Agnès Wacrenier; Xavier Leroy; Patrick Devos; Bruno Carnaille; Charles Proye; Jean Louis Wemeau; Martine Lecomte-Houcke; Emmanuelle Leteurtre
Journal:  Am J Surg Pathol       Date:  2002-12       Impact factor: 6.394

4.  Adrenal incidentaloma: clinical characteristics and comparison between patients with and without extraadrenal malignancy.

Authors:  G Tsvetov; I Shimon; C Benbassat
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

5.  Adrenal incidentalomas: experience in a developing country.

Authors:  P R K Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 6.  Proliferation markers and cell cycle inhibitors in pituitary adenomas.

Authors:  Wolfgang Saeger
Journal:  Front Horm Res       Date:  2004       Impact factor: 2.606

7.  An eleven-year experience with adrenocortical carcinoma.

Authors:  R F Pommier; M F Brennan
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

8.  [Metastatic pulmonary carcinoma, revealed by Cushing syndrome, initially considered to have a pituitary origin. Course over 25 years].

Authors:  J L de Gennes; D N Kiortsis; F Dairou; X Bertagna; M Malinsky
Journal:  Presse Med       Date:  1995-11-11       Impact factor: 1.228

9.  Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.

Authors:  P Komminoth; J Roth; S Schröder; P Saremaslani; P U Heitz
Journal:  Lab Invest       Date:  1995-04       Impact factor: 5.662

10.  Neuroendocrine differentiation of adrenocortical tumors.

Authors:  H R Haak; G J Fleuren
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.